The McCance Brain Care Score is an innovative composite metric that integrates 12 modifiable factors divided into three major domains: physical health measures, lifestyle behaviors, and social-emotional well-being indicators. Physical parameters include critical biomarkers such as blood pressure, blood glucose, cholesterol concentrations, and body mass index, whereas lifestyle components encompass smoking habits, alcohol consumption, diet quality, sleep regularity, and physical activity levels. Importantly, social-emotional factors assess the quality of interpersonal relationships, perceived stress, and an individual’s sense of purpose and meaningfulness in life, recognizing the multifaceted influences on cerebrovascular health.

Led by Dr. Nirupama Yechoor, MD, MSC, of Massachusetts General Hospital’s Department of Neurology—a key member institution within the Mass General Brigham integrated healthcare system—the team leveraged longitudinal data from the Women’s Health Study (WHS). This extensive clinical trial, renowned for its vast cohort and rigorous design, initially aimed to evaluate aspirin and vitamin E’s impact on cardiovascular and cancer outcomes in women. From a population of over 21,000 female participants with a median age just shy of 58, the investigators meticulously calculated baseline BCS values and tracked cerebrovascular event occurrences across more than two decades.

Their data reveal that each incremental increase of five points in the baseline BCS, around the cohort’s mean of 15 points, corresponds with a remarkable 37% reduction in the risk of experiencing either a stroke or transient ischemic attack during the follow-up timeline. This finding remained robust after adjusting for confounding variables including age, menopausal status, hormone replacement therapy, and an array of cardiovascular disease risk factors, emphasizing the BCS as an independent and reliable prognostic tool.

Stroke remains a formidable public health challenge, especially among women aged 55 to 75, where epidemiological estimates highlight that approximately 20% of this demographic are projected to suffer from cerebrovascular events during their lifetime. Prior investigations hinted at the predictive validity of the BCS in general populations for neurodegenerative diseases and affective disorders, but this study crucially establishes its focused applicability in middle-aged women, a group often underserved in stroke risk assessments.

The multidimensional nature of the BCS underscores the interconnectedness of varied physiological and psychosocial components underlying brain vascular health. Elevated blood pressure, dysregulated blood glucose, and undesirable lipid profiles create a biological milieu conducive to atherogenesis and cerebrovascular compromise. Simultaneously, unhealthy lifestyle practices such as smoking and physical inactivity exacerbate vascular insult, while stressful social environments and a low sense of life meaning may activate neuroendocrine pathways detrimental to cerebral circulation.

By harnessing the robust data from the Women’s Health Study, the researchers were able to conduct sophisticated statistical analyses with long-term follow-up, lending significant weight to their conclusions. The study’s strength lies in its comprehensive adjustment for potential confounders and its focus on modifiable factors, which inherently suggest actionable targets for preventive strategies and personalized interventions aimed at mitigating women’s stroke risk.

Dr. Devanshi Choksi, MBBS, MPH, as lead author and research fellow at MGH’s Neurology Department, highlights the study’s broader implications for public health. She emphasizes the potential for the McCance Brain Care Score to not only stratify risk at a population level but also to serve as a dynamic marker reflecting changes in lifestyle and health status over time. This opens avenues for continuous monitoring and tailored therapeutic approaches that may ultimately reduce the burden of cerebrovascular diseases.

The study’s comprehensive authorship team, consisting of experts in neurology, epidemiology, and brain health from Mass General Brigham and Harvard-affiliated institutions, showcases multidisciplinary collaboration essential for advancing translational research. Moreover, the study was generously funded by multiple prestigious entities including the Lavine Brain Health Innovation Fund, the American Heart Association, and the National Institutes of Health, underscoring the high regard and importance of research in cerebrovascular risk prediction.

It is notable that the McCance BCS offers an accessible framework based on measurable and modifiable factors, making it a practical tool for clinicians in varied healthcare settings aiming to integrate evidence-based risk stratification into routine care. Unlike complex genetic or imaging biomarkers which may impose financial or logistical barriers, the BCS’s incorporation of widely available clinical and lifestyle data could facilitate widespread adoption and scalable preventive strategies.

Looking ahead, the research team calls for expanded studies across more ethnically and socioeconomically diverse populations to validate and refine the McCance Brain Care Score’s predictive scope. Understanding how longitudinal fluctuations in the score reflect evolving stroke risk could revolutionize personalized medicine paradigms and inform public health campaigns centered on brain health preservation.

Overall, this pioneering research marks a significant stride forward in cerebrovascular disease prevention in women, aligning with global health priorities targeting stroke reduction. As cerebrovascular events continue to impose profound individual and societal costs, tools like the McCance Brain Care Score provide hope for earlier identification, effective intervention, and ultimately, enhanced quality of life through stroke risk mitigation.

Subject of Research: People

Article Title: Use of the Brain Care Score to Estimate the Risk of Incident Cerebrovascular Events in Middle-Aged Women

News Publication Date: 16-May-2025

Web References:

• https://www.massgeneralbrigham.org/
• https://www.neurology.org/doi/10.1212/WNL.0000000000213674
• https://whs.bwh.harvard.edu/

References:
Choksi, D. et al. “Use of the Brain Care Score to Estimate the Risk of Incident Cerebrovascular Events in Middle-Aged Women” Neurology DOI: 10.1212/WNL.0000000000213674

Keywords:
Vascular diseases, Central nervous system, Brain, Risk factors, Neurology

Patients classified as having mild carotid stenosis—less than 50% narrowing—have conventionally been considered low risk for recurrent ischemic events and thus managed conservatively with medical therapy alone. Yet clinical experience reveals a troubling paradox: despite optimal best medical therapy (BMT), a considerable subset of these patients continue to suffer strokes or transient ischemic episodes, signaling that traditional metrics may inadequately capture true vulnerability. This perplexing clinical scenario has galvanized researchers at Toyama University in Japan to investigate novel predictors of stroke risk beyond luminal stenosis severity.

Led by Lecturer Dr. Daina Kashiwazaki and neurosurgeon Dr. Satoshi Kuroda, the “Mild but Unstable Stenosis of Internal Carotid Artery” (MUSIC) study enrolled 124 patients across multiple centers who had suffered cerebrovascular or retinal ischemic events ipsilateral to mild carotid stenosis. The study, published in the prestigious Journal of Neurosurgery in early 2025, set out to rigorously characterize the clinical features, detailed radiological plaque characteristics, and longitudinal treatment outcomes in this underappreciated patient cohort. Importantly, all participants received best medical therapy tailored to their risk factors, while approximately half also underwent surgical intervention via carotid endarterectomy (CEA) or carotid artery stenting (CAS).

What sets the MUSIC study apart is its intensive focus on plaque composition, rather than solely the degree of arterial narrowing, as a determinant of future ischemic events. Advanced neuroimaging techniques identified a strikingly high prevalence of unstable plaque features in the cohort: around 81% exhibited radiologically unstable plaques, and nearly 60% harbored intraplaque hemorrhage (IPH)—a pathologic hallmark indicative of plaque vulnerability and active disease. IPH, characterized by bleeding within the atherosclerotic lesion, is known to accelerate plaque progression, increase inflammation, and dramatically elevate the risk of rupture and thrombosis.

The prognostic implications of these findings were profound. Patients with IPH faced a significantly elevated risk of ipsilateral ischemic stroke and other cerebrovascular endpoints, including ocular ischemic symptoms and progression necessitating surgical intervention. Critically, the incidence of ischemic stroke over two years was substantially lower—just 1.7%—in patients who received surgical plaque removal via CEA compared to 15.1% in those managed with best medical therapy alone. These data unequivocally position plaque instability and hemorrhagic components as pivotal risk modulators, overshadowing luminal stenosis percentage in symptomatic mild carotid disease.

Such insights disrupt existing clinical guidelines that traditionally reserve CEA for patients with moderate to severe stenosis, generally excluding those with mild disease. The MUSIC study’s findings advocate for a paradigm shift towards personalized stroke prevention strategies that incorporate detailed plaque imaging to stratify risk and guide treatment. By identifying high-risk patients with unstable plaque features early, clinicians could intervene surgically before disabling ischemic events occur. This more nuanced approach holds the promise to transform prophylactic stroke care in millions worldwide.

Another remarkable facet highlighted by the study is the observation that nearly half of the participants were already receiving antithrombotic agents prior to enrollment but continued to experience ischemic events. This suggests that conservative medical management alone may be insufficient, or that therapeutic resistance may exist in this subgroup with unstable mild carotid stenosis. The identification of such resistance underscores the urgent need for alternative strategies, including surgical plaque removal, to avert catastrophic outcomes.

From a pathophysiological perspective, the study reinforces the concept that the composition and biological activity of atherosclerotic plaques—rather than static luminal narrowing—drive the natural history of ischemic stroke risk. Intraplaque hemorrhage triggers a vicious cycle of inflammation, neovascular proliferation, and plaque destabilization, which culminate in embolic strokes even in arterial segments with less than 50% stenosis. These dynamic plaque processes cannot be captured by traditional angiographic stenosis assessment, necessitating advanced imaging modalities such as high-resolution magnetic resonance imaging (MRI) for adequate risk appraisal.

The potential clinical repercussions of adopting plaque composition evaluation are sweeping. Preoperative assessment of IPH and other high-risk plaque morphologies would enable neurosurgeons and neurologists to tailor individualized treatment plans, selectively recommending carotid endarterectomy for those who stand to benefit most while sparing low-risk patients from unnecessary surgery. This approach promises to enhance patient safety, improve functional outcomes, and optimize resource allocation in vascular neurosurgery.

Looking ahead, the MUSIC investigators envision integrating plaque characterization into routine clinical algorithms for all individuals presenting with symptomatic mild carotid stenosis. This forward-thinking strategy departs from the traditional stenosis-threshold model and advocates for a more sophisticated, biology-driven framework that addresses the heterogeneity of atherosclerotic disease. Through wider adoption, such paradigm shifts could ultimately reduce the global burden of stroke by intercepting high-risk patients before irreversible neurological damage occurs.

While the study’s prospective design and multicenter enrollment strengthen its validity, further research is warranted to corroborate these findings across diverse populations and to refine imaging protocols and treatment thresholds. Moreover, investigating adjunctive pharmacotherapies aimed specifically at stabilizing vulnerable plaques represents a promising avenue to complement surgical interventions. Ultimately, multidisciplinary collaboration combining advanced neuroimaging, vascular neurosurgery, and precision medicine will be vital to translating these insights into clinical practice.

In conclusion, the MUSIC study from Toyama University decisively challenges the prevailing clinical mindset that views symptomatic mild carotid stenosis as inherently low risk. By illuminating the critical role of plaque instability and intraplaque hemorrhage in precipitating recurrent ischemic events, this research heralds a new era in stroke prevention. The shift towards incorporating plaque composition evaluation into patient assessment heralds a future where individualized, mechanism-based interventions supplant crude stenosis metrics, offering new hope for patients previously deemed low risk yet suffering devastating strokes. This transformative work underscores the pressing necessity for personalized approaches in vascular neurology and neurosurgery and exemplifies the impact of targeted research in improving global health outcomes.

—

Subject of Research: People

Article Title: Clinical features, radiological findings, and outcome in patients with symptomatic mild carotid stenosis: a MUSIC study

News Publication Date: February 21, 2025

Web References: https://doi.org/10.3171/2024.10.JNS241185

References: Kashiwazaki D, Kuroda S, et al. Clinical features, radiological findings, and outcome in patients with symptomatic mild carotid stenosis: a MUSIC study. Journal of Neurosurgery. Published online February 21, 2025. DOI: 10.3171/2024.10.JNS241185

Image Credits: Lecturer Daina Kashiwazaki from Toyama University, Japan

Keywords: Carotid artery, Medical treatments, Risk factors, Ischemia, Atherosclerosis, Bleeding